Trial · NCT01294683
Participant flow14
How many started, completed or left each group, period by period.
1 to 14 of 14
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Precrossover (Periods I/II) | STARTED | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 489 | |
| Precrossover (Periods I/II) | STARTED | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 488 | |
| Precrossover (Periods I/II) | Treated | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 486 | |
| Precrossover (Periods I/II) | Treated | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 486 | |
| Precrossover (Periods I/II) | COMPLETED | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 232 | |
| Precrossover (Periods I/II) | COMPLETED | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 222 | |
| Precrossover (Periods I/II) | NOT COMPLETED | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 257 | |
| Precrossover (Periods I/II) | NOT COMPLETED | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 266 | |
| Post Crossover (Period III) | STARTED | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 232 | |
| Post Crossover (Period III) | STARTED | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 222 | |
| Post Crossover (Period III) | COMPLETED | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 199 | |
| Post Crossover (Period III) | COMPLETED | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 190 | |
| Post Crossover (Period III) | NOT COMPLETED | Sequence 1: MK-0524B 2g/40g→MK-0524A 2g + Simvastatin 40 mg | 33 | |
| Post Crossover (Period III) | NOT COMPLETED | Sequence 2: MK-0524A 2g + Simvastatin 40 mg→ MK-0524B 2g/40g | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01294683/flow